1st Mar 2021 11:29
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.
----------
AIM - WINNERS
----------
Tlou Energy, up 18% at 3.90 pence, 12-month range 1.22p-4.91p. Energy firm says in funding discussions for Lesedi power project in Botswana. Says advanced project finance discussions are currently with an unnamed "very reputable Botswana based entity".
----------
MyHealthChecked, up 17% at 3.82p, 12-month range 0.6p-4.9p. The healthcare company notes increase in its share price and says it has become aware of speculation over the weekend that a significant potential contract is in the pipeline. Says that while it is engaged in commercial discussions with a number of parties for the supply of Covid-19 testing kits, no contracts have been signed to date, nor is there any certainty that any of these discussions will result in commercial agreement.
----------
Lexington Gold, up 13% at 4.0p, 12-month range 1.0p-4.2p. The gold miner says that drilling operations have commenced at its Jones-Keystone-Loflin project within the Carolina Slate Belt.
----------
Prospex Energy, up 10% at 2.15p, 12-month range 1.4p-93.13p. The energy investor announces completion of acquisition of a 50% interest in El Romeral gas and power operation in Spain - includes three producing wells and 8.1 megawatt power station.
----------
AIM - LOSERS
----------
Lansdowne Oil & Gas, down 19% at 0.97p, 12-month range 0.2p-2.78p. Providence Resources, down 14% at 4.63p, 12-month range 1.0p-8.84p. The oil and gas firms say funding with SpotOn Energy has not so far been secured and Barryroe Partners have agreed to allow an extension of two months to April 30 for the funding to be put in place. Lansdowne and Providence had signed a farm out agreement with SpotOn in November in relation to farm out of standard exploration license 1/11. The standard exploration license 1/11 contains the Barryroe oil and gas field in which the Providence has an 80% stake and Lansdowne has a 20% stake.
----------
Physiomics, down 7.7% at 7.2%, 12-month range 1.3p-17.25p. The oncology consultancy posts fall in interim earnings. For half year to December 31, revenue down GBP363,000 from GBP343,000 prior year and pretax loss widens to GBP132,000 from GBP118,000.
---------
By Arvind Bhunjun; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
TLOU ENERGYPVR.LPhysiomicsProspex EngMyhlth Chck